Accelerating Kids’ Access to Care Act This bill requires states to establish a process through which qualifying out-of-state providers may temporarily treat children under Medicaid and the Children's Health Insurance Program (CHIP) without undergoing additional screening requirements. Specifically, states must establish a process through which qualifying out-of-state providers may enroll for five years as participating providers to treat individuals under the age of 21 without undergoing additional screening requirements. A qualifying out-of-state provider (1) must not have been excluded or terminated from participating in a federal health care program or state Medicaid program; and (2) must have been successfully enrolled in Medicare or a state Medicaid program based on a determination that the provider posed a limited risk of fraud, waste, or abuse. The bill’s changes take effect three years after enactment.
Read twice and referred to the Committee on Finance.
Bill introduced
Lobbying filed by AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
Lobbying filed by AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
Lobbying filed by AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
Lobbying filed by AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
Read twice and referred to the Committee on Finance.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $4.8M | Apr 21, 2025 | 2025Q1 | HCRMMMINS |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $4.0M | Jul 21, 2025 | 2025Q2 | HCRMMMINS |
The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.
Lobbying filed by NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC |
| $2.6M |
| Jul 21, 2025 |
| 2025Q2 |
HCRTAXTOB |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. | AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | $2.0M | Apr 21, 2025 | 2025Q1 | HCRTAXTOB |
| NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES | NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) | $1.8M | Jul 21, 2025 | 2025Q2 | HCRMMMDEF |
| NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES | NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) | $1.4M | Apr 21, 2025 | 2025Q1 | HCRMMMDEF |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | $1.1M | Jul 21, 2025 | 2025Q2 | BUDHCRMMM |
| AMERICAN HEART ASSOCIATION | AMERICAN HEART ASSOCIATION | $650.0K | Jul 27, 2025 | 2025Q2 | AGRGOVTRA |
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | $650.0K | Jul 17, 2025 | 2025Q2 | MMMHCRTOB |
| AMERICAN LUNG ASSOCIATION | AMERICAN LUNG ASSOCIATION | $560.0K | Jul 21, 2025 | 2025Q2 | BUDCAWHCR |
| ACADIA PHARMACEUTICALS | ACADIA PHARMACEUTICALS | $500.0K | Jul 21, 2025 | 2025Q2 | TAXHCRMMM |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | $390.0K | Apr 21, 2025 | 2025Q1 | HCRMMMTAR |
| AMERICAN ACADEMY OF PEDIATRICS | AMERICAN ACADEMY OF PEDIATRICS | $380.0K | Apr 23, 2025 | 2025Q1 | HCR |
| CYSTIC FIBROSIS FOUNDATION | CYSTIC FIBROSIS FOUNDATION | $300.0K | Jul 21, 2025 | 2025Q2 | HCRINSBUD |
| NATIONAL MARROW DONOR PROGRAM | NATIONAL MARROW DONOR PROGRAM | $300.0K | Apr 21, 2025 | 2025Q1 | HCRBUDLBR |
| AMERICAN HEART ASSOCIATION | AMERICAN HEART ASSOCIATION | $290.0K | Apr 24, 2025 | 2025Q1 | BUDTOBHCR |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | $270.0K | Jul 21, 2025 | 2025Q2 | HCRMMMTAR |
| NATIONAL MARROW DONOR PROGRAM | NATIONAL MARROW DONOR PROGRAM | $270.0K | Jul 17, 2025 | 2025Q2 | HCRBUDTRA |
| THE SOCIETY OF THORACIC SURGEONS | THE SOCIETY OF THORACIC SURGEONS | $261.1K | Apr 22, 2025 | 2025Q1 | MMMEDUMED |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | $260.0K | Jul 18, 2025 | 2025Q2 | HCRBUD |
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | $250.0K | Apr 17, 2025 | 2025Q1 | MMMHCRTOB |
| CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | $240.0K | Apr 16, 2025 | 2025Q1 | BUDMMMWEL |
| ORCHARD THERAPEUTICS NORTH AMERICA | ORCHARD THERAPEUTICS NORTH AMERICA | $220.0K | Jul 17, 2025 | 2025Q2 | HCRMMM |
| AMERICAN ACADEMY OF PEDIATRICS | AMERICAN ACADEMY OF PEDIATRICS | $210.0K | Jul 21, 2025 | 2025Q2 | HCR |
| CYSTIC FIBROSIS FOUNDATION | CYSTIC FIBROSIS FOUNDATION | $200.0K | Apr 21, 2025 | 2025Q1 | HCRINSBUD |
| SPARK THERAPEUTICS, INC. | SPARK THERAPEUTICS, INC. | $190.0K | Apr 21, 2025 | 2025Q1 | MMMHCR |
| ALLIANCE FOR REGENERATIVE MEDICINE | ALLIANCE FOR REGENERATIVE MEDICINE | $160.0K | Jul 23, 2025 | 2025Q2 | HCR |
| THE SOCIETY OF THORACIC SURGEONS | THE SOCIETY OF THORACIC SURGEONS | $156.0K | Jul 21, 2025 | 2025Q2 | MMMEDUMED |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | $150.0K | Apr 20, 2025 | 2025Q1 | HCRBUD |
| ALLIANCE FOR REGENERATIVE MEDICINE | ALLIANCE FOR REGENERATIVE MEDICINE | $140.0K | Apr 21, 2025 | 2025Q1 | HCR |
| CHILDREN'S HOSPITAL BOSTON | CHILDREN'S HOSPITAL BOSTON | $130.0K | May 6, 2025 | 2025Q1 | HCRMEDMMM |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | $130.0K | Apr 22, 2025 | 2025Q1 | BUDHCRMMM |
| CHILDREN'S HOSPITAL BOSTON | CHILDREN'S HOSPITAL BOSTON | $110.0K | Jul 22, 2025 | 2025Q2 | HCRMEDMMM |
| STEALTH BIOTHERAPEUTICS INC. | STEALTH BIOTHERAPEUTICS INC. | $110.0K | Jul 21, 2025 | 2025Q2 | HCR |
| DANA-FARBER CANCER INSTITUTE | DANA-FARBER CANCER INSTITUTE | $92.0K | Jul 15, 2025 | 2025Q2 | BUDHCRMMM |
| CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | $90.0K | Jul 17, 2025 | 2025Q2 | BUDMMM |
| INVARIANT LLC | NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS | $90.0K | Jul 17, 2025 | 2025Q2 | HCRMMMDEF |
| TEXAS CHILDREN'S HOSPITAL | TEXAS CHILDREN'S HOSPITAL | $80.0K | Jul 21, 2025 | 2025Q2 | BUDHCRMMM |
| TEXAS CHILDREN'S HOSPITAL | TEXAS CHILDREN'S HOSPITAL | $80.0K | Apr 21, 2025 | 2025Q1 | MEDBUDHCR |
| DANA-FARBER CANCER INSTITUTE | DANA-FARBER CANCER INSTITUTE | $77.7K | Apr 16, 2025 | 2025Q1 | BUDHCRMMM |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | NATIONAL MULTIPLE SCLEROSIS SOCIETY | $70.7K | Jul 21, 2025 | 2025Q2 | BUDHCRMMM |
| MEHLMAN CONSULTING, INC. | ULTRAGENYX PHARMACEUTICAL, INC. | $60.0K | Jul 21, 2025 | 2025Q2 | HCR |
| KOUNTOUPES DENHAM CARR & REID, LLC | BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) | $60.0K | Jul 17, 2025 | 2025Q2 | HCRMMMTAX |
| MEHLMAN CONSULTING, INC. | ULTRAGENYX PHARMACEUTICAL, INC. | $60.0K | Apr 17, 2025 | 2025Q1 | HCR |
| KOUNTOUPES DENHAM CARR & REID, LLC | BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) | $60.0K | Apr 15, 2025 | 2025Q1 | HCRMMMTAX |
| AVENUE SOLUTIONS | ALLIANCE FOR REGENERATIVE MEDICINE | $50.0K | Jul 21, 2025 | 2025Q2 | MMM |
| THE NICKLES GROUP, LLC | CLEVELAND CLINIC FOUNDATION | $50.0K | Jul 17, 2025 | 2025Q2 | MMMHCRIMM |
| THE KPM GROUP DC LLC | SOLENO THERAPEUTICS, INC. | $50.0K | Jul 17, 2025 | 2025Q2 | HCR |
| THE KPM GROUP DC LLC | SOLENO THERAPEUTICS, INC. | $50.0K | Apr 21, 2025 | 2025Q1 | HCR |
| STEALTH BIOTHERAPEUTICS INC. | STEALTH BIOTHERAPEUTICS INC. | $50.0K | Apr 21, 2025 | 2025Q1 | HCR |
| AVENUE SOLUTIONS | ALLIANCE FOR REGENERATIVE MEDICINE | $50.0K | Apr 21, 2025 | 2025Q1 | MMM |
| VIRGINIA COMMONWEALTH UNIVERSITY | VIRGINIA COMMONWEALTH UNIVERSITY | $50.0K | Apr 20, 2025 | 2025Q1 | EDUHCR |
| FAEGRE DRINKER BIDDLE & REATH LLP | BOSTON CHILDREN'S HOSPITAL | $40.0K | Jul 17, 2025 | 2025Q2 | HCRMMM |
| THE KPM GROUP DC LLC | PRAXIS PRECISION MEDICINES | $40.0K | Jul 17, 2025 | 2025Q2 | PHA |
| FAEGRE DRINKER BIDDLE & REATH LLP | CHILDREN'S HOSPITAL COLORADO | $40.0K | Jul 17, 2025 | 2025Q2 | HCRMMMDEF |
| THE KPM GROUP DC LLC | ASTRIA THERAPEUTICS, INC. | $40.0K | Jul 17, 2025 | 2025Q2 | PHA |
| EVERYLIFE FOUNDATION FOR RARE DISEASES | EVERYLIFE FOUNDATION FOR RARE DISEASES | $40.0K | Jul 17, 2025 | 2025Q2 | HCR |
| THE KPM GROUP DC LLC | PRAXIS PRECISION MEDICINES | $40.0K | Apr 21, 2025 | 2025Q1 | PHA |
| THE NICKLES GROUP, LLC | CLEVELAND CLINIC FOUNDATION | $40.0K | Apr 21, 2025 | 2025Q1 | MMMHCRIMM |
| THE KPM GROUP DC LLC | ASTRIA THERAPEUTICS, INC. | $40.0K | Apr 21, 2025 | 2025Q1 | PHA |
| ARENTFOX SCHIFF LLP | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | $30.0K | Jul 21, 2025 | 2025Q2 | HCRBUD |
| EVERYLIFE FOUNDATION FOR RARE DISEASES | EVERYLIFE FOUNDATION FOR RARE DISEASES | $30.0K | Apr 21, 2025 | 2025Q1 | HCR |
| LMH STRATEGIC SOLUTIONS | ORCHARD THERAPEUTICS NORTH AMERICA | $30.0K | Apr 18, 2025 | 2025Q1 | HCR |
| FAEGRE DRINKER BIDDLE & REATH LLP | BOSTON CHILDREN'S HOSPITAL | $30.0K | Apr 10, 2025 | 2025Q1 | HCRMMM |
| TERUMO BCT, INC. | TERUMO BCT, INC. | $20.0K | Jul 22, 2025 | 2025Q2 | TRDHCR |
| ARTEMIS POLICY GROUP LLC | SICKLE CELL DISEASE ASSOCIATION OF AMERICA | $20.0K | Jul 18, 2025 | 2025Q2 | HCRMMMBUD |
| NATIONAL ALLIANCE ON MENTAL ILLNESS | NATIONAL ALLIANCE ON MENTAL ILLNESS | $20.0K | Jul 18, 2025 | 2025Q2 | HCRBUDLAW |
| FAEGRE DRINKER BIDDLE & REATH LLP | EVERYLIFE FOUNDATION FOR RARE DISEASES | $20.0K | Jul 17, 2025 | 2025Q2 | HCRBUDMMM |
| LEAVITT PARTNERS, LLC | ORCHARD THERAPEUTICS NORTH AMERICA | $20.0K | Jul 15, 2025 | 2025Q2 | HCR |
| ARTEMIS POLICY GROUP LLC | SICKLE CELL DISEASE ASSOCIATION OF AMERICA | $20.0K | Apr 21, 2025 | 2025Q1 | HCRMMMBUD |
| LMH STRATEGIC SOLUTIONS | IONIS PHARMACEUTICALS, INC. | $20.0K | Apr 18, 2025 | 2025Q1 | HCR |
| TERUMO BCT, INC. | TERUMO BCT, INC. | $20.0K | Apr 16, 2025 | 2025Q1 | TRDHCR |
| FAEGRE DRINKER BIDDLE & REATH LLP | CHILDREN'S HOSPITAL COLORADO | $20.0K | Apr 10, 2025 | 2025Q1 | HCRMMMDEF |
| FAEGRE DRINKER BIDDLE & REATH LLP | EVERYLIFE FOUNDATION FOR RARE DISEASES | $20.0K | Apr 10, 2025 | 2025Q1 | HCRBUDMMM |
| NATIONAL ALLIANCE ON MENTAL ILLNESS | NATIONAL ALLIANCE ON MENTAL ILLNESS | $10.0K | Apr 21, 2025 | 2025Q1 | HCRBUDLAW |
| FAMILY RESEARCH COUNCIL | FAMILY RESEARCH COUNCIL | Undisclosed | Apr 17, 2025 | 2025Q1 | EDUHCRCIV |